+499.5%
MRNA vs SPMO
+29.9%
+469.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SPMO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.6% | -3.8% | -2.3% |
| 7D | +5.5% | +2.0% | +3.5% | +5.3% |
| 30D | +158.7% | -0.4% | +159.1% | +158.2% |
| 3M | +182.1% | -1.9% | +184.0% | +175.4% |
| 6M | +151.8% | +25.0% | +126.8% | +98.3% |
| YTD | +393.6% | +26.0% | +367.5% | +286.3% |
| 1Y | +499.5% | +28.7% | +470.8% | +359.9% |
| All | +499.5% | +29.9% | +469.5% | +359.9% |
Cumulative growth
Daily Returns
Daily percentage return beside SPMO.
Daily Out/Under-Performance
Portfolio return minus SPMO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPMO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SPMO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling